首页> 外文期刊>Luminescence: The journal of biological and chemical luminescence >Multiway analysis applied to time-resolved chemiluminescence for simultaneous determination of paracetamol and codeine in pharmaceuticals
【24h】

Multiway analysis applied to time-resolved chemiluminescence for simultaneous determination of paracetamol and codeine in pharmaceuticals

机译:多路分析应用于时间分辨化学发光法同时测定药物中对乙酰氨基酚和可待因

获取原文
获取原文并翻译 | 示例
           

摘要

This method is based on the enhancing effect of codeine (COD) and paracetamol (PAR) on the chemiluminescence (CL) reaction of Ru(phen)(3)(2+) with Ce(IV). In the batch mode, COD gives a relatively sharp peak with the highest CL intensity at 4.0s, whereas the maximum CL intensity of the PAR appears at similar to 60s after injection of Ce(IV) solution. Whole CL time profiles allowed use of the time-resolved CL data in combination with multiway calibration techniques, as multiway partial least squares (N-PLS), for the quantitative determination of both COD and PAR in binary mixtures. In this work, we found that the impact of Ce(IV) concentration on the CL intensity was different for COD and PAR. Therefore, a Ce(IV) concentration mode was added to the time and sample modes to obtain 3D data. The percent relative standard deviation (%RSD) values for 10 determinations of 1.0x10(-5)mol/L of COD and 1.0x10(-4)mol/L of PAR were 6.1% and 8.7%, respectively. The limit of detection (LOD) values (S/N=3) were 0.9x10(-8)mol/L and 1.0x10(-6)mol/L for COD and PAR, respectively. The proposed method was successfully applied to the determination of PAR and COD in commercial pharmaceutical formulations. Acceptable recoveries (90-110%) were obtained for the quantification of these drugs in the real samples. Copyright (c) 2016 John Wiley & Sons, Ltd.
机译:此方法基于可待因(COD)和扑热息痛(PAR)对Ru(phen)(3)(2+)与Ce(IV)的化学发光(CL)反应的增强作用。在分批模式下,COD给出一个相对尖锐的峰,在4.0s时具有最高的CL强度,而PAR的最大CL强度在注入Ce(IV)溶液后的60s出现。整个CL时间曲线允许将时间分辨的CL数据与多路校准技术结合使用,作为多路偏最小二乘(N-PLS),用于定量测定二元混合物中的COD和PAR。在这项工作中,我们发现对于COD和PAR,Ce(IV)浓度对CL强度的影响是不同的。因此,将Ce(IV)浓度模式添加到时间和采样模式中以获得3D数据。 10次​​测定的COD 1.0x10(-5)mol / L和PAR 1.0x10(-4)mol / L的相对标准偏差百分比(%RSD)值分别为6.1%和8.7%。 COD和PAR的检出限(LOD)值(S / N = 3)分别为0.9x10(-8)mol / L和1.0x10(-6)mol / L。所提出的方法已成功应用于商业药物制剂中PAR和COD的测定。对于真实样品中的这些药物,获得了可接受的回收率(90-110%)。版权所有(c)2016 John Wiley&Sons,Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号